FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Endo Recalls Robaxin Due to Labeling Error

[ Price : $8.95]

Endo International recalls two lots of Robaxin (methocarbamol tablets, USP) 750mg tablets in 100-count bottle packs due to some pr...

FDA Warns About Dosing Errors with Compounded Injectables

[ Price : $8.95]

FDA says it has received reports of dosing errors and confusion with the labeled strength expression for certain compounded inject...

Draft Guide on Human Factors Submissions

[ Price : $8.95]

Federal Register notice: FDA releases a draft guidance entitled Contents of a Complete Submission for Threshold Analyses and Human...

Draft Guide on Adaptive Trial Designs

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance entitled Adaptive Designs for Clinical Trials of Drugs and Biologics...

Draft Guide on Master Protocol Trial Designs

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guide entitled Master Protocols: Efficient Clinical Trial Design Strategies t...

Oscor Recalls TB Bipolar Pacing Leads

[ Price : $8.95]

Oscor Inc. recalls its TB Temporary Bipolar Pacing Lead (unshrouded 2 mm Pins Models) due to connectivity concerns.

Ventana Class 1 Recall of Detection Kits

[ Price : $8.95]

Ventana Medical Systems recalls (Class 1) multiple detection kits due to a potential for false negative results caused by reagent ...

FDA Updates Device Cybersecurity Activities

[ Price : $8.95]

FDA says it is preparing a significant update to its guidance on Content of Premarket Submissions for Management of Cybersecurity ...

Special 510(k) Pilot Program Begins 10/1

[ Price : $8.95]

FDA launches a revised Special 510(k) Pilot Program that aims to expand on the types of changes eligible for the program to improv...

Former Able Labs Quality Manager Debarred

[ Price : $8.95]

Federal Register notice: FDA denies a request for a hearing from Dilip Patel and is issuing an order to debar Patel for five years...